- Home
- MTH vs LNTH Comparison
MTH vs LNTH Comparison
Compare MTH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTH
- LNTH
- Stock Information
- Founded
- MTH 1985
- LNTH 1956
- Country
- MTH United States
- LNTH United States
- Employees
- MTH N/A
- LNTH N/A
- Industry
- MTH Homebuilding
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MTH Consumer Discretionary
- LNTH Health Care
- Exchange
- MTH Nasdaq
- LNTH Nasdaq
- Market Cap
- MTH 4.9B
- LNTH 5.7B
- IPO Year
- MTH 1988
- LNTH 2015
- Fundamental
- Price
- MTH $70.63
- LNTH $80.42
- Analyst Decision
- MTH Buy
- LNTH Strong Buy
- Analyst Count
- MTH 10
- LNTH 5
- Target Price
- MTH $74.42
- LNTH $131.20
- AVG Volume (30 Days)
- MTH 929.3K
- LNTH 999.3K
- Earning Date
- MTH 07-23-2025
- LNTH 07-30-2025
- Dividend Yield
- MTH 2.44%
- LNTH N/A
- EPS Growth
- MTH N/A
- LNTH N/A
- EPS
- MTH 9.89
- LNTH 3.53
- Revenue
- MTH $6,284,888,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- MTH $3.99
- LNTH $4.63
- Revenue Next Year
- MTH $7.59
- LNTH $9.35
- P/E Ratio
- MTH $7.14
- LNTH $22.77
- Revenue Growth
- MTH N/A
- LNTH 12.53
- 52 Week Low
- MTH $59.27
- LNTH $73.11
- 52 Week High
- MTH $106.99
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- MTH 60.43
- LNTH 48.55
- Support Level
- MTH $66.00
- LNTH $78.41
- Resistance Level
- MTH $73.01
- LNTH $82.50
- Average True Range (ATR)
- MTH 2.46
- LNTH 2.17
- MACD
- MTH 0.81
- LNTH 0.41
- Stochastic Oscillator
- MTH 78.21
- LNTH 66.23
About MTH Meritage Homes Corporation
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.